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Abstract
Background: Pancreatic cancer is the fourth leading cause of cancer death in the United States.
Consequently, identification of clinically relevant biomarkers for the early detection of this cancer
type is urgently needed. In recent years, proteomics profiling techniques combined with various
data analysis methods have been successfully used to gain critical insights into processes and
mechanisms underlying pathologic conditions, particularly as they relate to cancer. However, the
high dimensionality of proteomics data combined with their relatively small sample sizes poses a
significant challenge to current data mining methodology where many of the standard methods
cannot be applied directly. Here, we propose a novel methodological framework using machine
learning method, in which decision tree based classifier ensembles coupled with feature selection
methods, is applied to proteomics data generated from premalignant pancreatic cancer.
Results: This study explores the utility of three different feature selection schemas (Student t test,
Wilcoxon rank sum test and genetic algorithm) to reduce the high dimensionality of a pancreatic
cancer proteomic dataset. Using the top features selected from each method, we compared the
prediction performances of a single decision tree algorithm C4.5 with six different decision-tree
based classifier ensembles (Random forest, Stacked generalization, Bagging, Adaboost, Logitboost
and Multiboost). We show that ensemble classifiers always outperform single decision tree
classifier in having greater accuracies and smaller prediction errors when applied to a pancreatic
cancer proteomics dataset.
Conclusion: In our cross validation framework, classifier ensembles generally have better
classification accuracies compared to that of a single decision tree when applied to a pancreatic
cancer proteomic dataset, thus suggesting its utility in future proteomics data analysis. Additionally,
the use of feature selection method allows us to select biomarkers with potentially important roles
in cancer development, therefore highlighting the validity of this method.
Background
Pancreatic cancer is one of the most lethal types of cancer.
In United States, there are ~30,000 new cases being diag-
nosed each year. The mortality rate of pancreatic cancer
patients is approaching 100%. Only 4% of the patients
survive 5 years or more after being diagnosed. The grim
statistics of pancreatic cancer necessitates the urgent devel-
opment of methods to facilitate their early detection and
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edge in recent years regarding the pathophysiology of
pancreatic cancer [2,3], we still lack an effective method to
diagnose this cancer type early enough to impact the treat-
ment outcomes.
Recently, there has been substantial interests in applying
proteomics technology to identify clinically useful
biomarkers for early-stage pancreatic cancer [4-11]. In a
more general sense, many investigators have applied pro-
teomics technology and data mining methods to identify
serum proteomic patterns that can distinguish normal
from cancer samples. Examples of these include ovarian
cancer [12-17], breast cancer [18,19], prostate cancer [20-
22], lung cancer [23], brain tumors [24], and head and
neck cancer [25].
One of the major challenges for proteomic profiling is the
analysis and mining of biologically useful information
from the enormous dataset. Due to the high dimensional-
ity of proteomics dataset and their often small sample
sizes, non-classical statistical methods for data analysis
need to be employed. Therefore, various machine learn-
ing classification algorithms have been applied to pro-
teomics data analysis. These include the use of decision
tree [26,27], boosted decision tree [28], random forest
[29], nearest centroid [30], Bayesian neural network [31],
self-organizing map [32], support vector machine [33,34],
linear and quadratic discriminant analysis [35] and meta-
learners [36,37]. However, there are limitations regarding
these studies [38-41]. These include the lack of efficient
procedure for biomarker selection and the inability to
cope with data noise. More importantly, most of these
classification methods were constructed based on a single
classifier derived from a single training process. They are
not robust enough to handle the great variance inherent
in the proteomics data. Thus, a more general machine
learning method is needed to overcome these challenges.
Here, we present a computational method to analyze a
proteomics dataset obtained from premalignant pancre-
atic cancer using decision tree based classifier ensembles
coupled with three feature selection schemas and show
that classifier ensembles always have better performances
compared to a single decision tree and other models.
Results
The premalignant pancreatic cancer mass spectrometry
dataset used in this study include 181 samples. Of the 181
samples, 101 are control serum samples and 80 are PanIN
(pancreatic intraepithelial neoplasias) samples. Control
samples are referred to as normal cases while PanIN sam-
ples as disease cases. The complete computational proce-
dure used in this study is shown in Figure. 1. After
preprocessing, we ran our processed data through a 10
fold cross-validation framework. In each round of the
cross validation, 90% of the data were selected randomly
as training set to build classifier. Three feature selection
methods were applied to select top features (mass to
charge ratios, m/z) from the training set only. Classifiers
were then tested on the rest of the 10% data using those
selected features. The performances of various classifiers
were also compared.
Data preprocessing
To compensate for systematic differences due to sample
loadings and instrument errors, raw proteomics data have
to be preprocessed before any feature selection method
and classification algorithm can be applied. Three major
preprocessing procedures were applied to our dataset:
baseline adjustment, normalization and kernel smooth-
ing. Using one specific spectrogram as an example, the
effects of these processing operations on the raw data are
shown in Figure. 2. The original spectrograms consist of
6771 different m/z ratios and they range from 800 to
11992.91 in their values (Figure. 2A). The spectrogram
baselines were adjusted based on the group median (Fig-
ure. 2B). All data points were smoothed by substituting
their values with the weighted average of 5 value points on
each side using a Gaussian kernel (Figure. 2C). Using the
area under each spectrogram curve (AUG), all spectro-
grams were normalized and rescaled such that their max-
imum values equal to 100 (Figure. 2D).
Biomarker identification
In general, classifiers cannot successfully handle high
dimensional dataset generated from proteomics experi-
ments. To overcome this problem, we used three feature
selection schemes (Student t test, Wilcoxon rank sum test
and genetic algorithm) to reduce the dimensionality of
the dataset to a manageable number. Table. 1 lists all the
top 10 features generated from each round of two-sample
homoscedastic t test. These features are ranked based on
their p-values that correspond to the probability of their
observed differences in mean intensity between control
and disease group being significant. Interestingly, several
features (m/z ratios) such as 5798.9 and 5801.2 were
repeatedly selected in our 10 rounds of cross validation
analyses despite the fact that the training dataset is ran-
domly selected from the whole dataset each time. Regard-
less of how the data is partitioned, highly significant
differences in peptides' m/z intensity between control and
disease samples can and will likely be selected each time.
Thus, these m/z ratios are considered potentially good
biomarkers for disease identification. The use of ran-
domly selected training data provides greater confidence
to our results.
While t test assumes that the feature values from two dif-
ferent classes follow normal distributions. In reality, thisPage 2 of 12
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of using a nonparametric (distribution-free) test to select
our top features. The top 10 features selected from Wil-
coxon nonparametric rank test are presented in Table 2.
Similar to t test, some of the m/z ratios such as 5798.9 and
5801.2 were also selected frequently. Features that are
repeatedly selected from independent runs suggest that
those features play important roles in discriminating
between normal and disease classes.
To compare with filter feature selection method such as t
test and Wilcoxon rank test, we also explored the possible
utility of a wrapper method, specifically the use of genetic
algorithm coupled with linear discriminant analysis. In
contrast to t test and Wilcoxon rank test in which several
features were repeatedly selected, genetic algorithm pro-
vided a very different result. As shown in Table 3, features
selected from each round are quite different, with no fea-
ture being selected more than twice in 10 rounds of cross-
validation. One possible reason for this result is that the
initial population size used by the genetic algorithm was
small and that it was randomly selected from the training
set. Due to its small population size (10 features in a pop-
ulation), any particular feature is less likely to be selected
repeatedly by random sampling.
Classification results and comparisons
After data dimension reduction using methods men-
tioned above, we tested and compared the performances
of a single decision tree algorithm C4.5, six different deci-
sion tree-based classifier ensembles, and six different
benchmark classification algorithms in a 10 fold cross val-
idation framework. Default parameters were used in all
algorithms without any fine-tuning of individual classi-
fier, thus, allowing us to compare the performance of each
algorithm. Because no particular classifier is preferred,
potential misleading conclusion can be avoided.
Table 4 lists the average performances of all algorithms in
a 10-fold cross validation using selected features from t
test. In terms of accuracy, all classifier ensembles such as
Bagging and Multiboost outperformed single decision
tree (64% accurate) or at least had similar results. Moreo-
ver, the fact that single decision tree C4.5 has the best pre-
diction sensitivity (0.99) and lowest specificity (0.21)
indicates that this model was well adapted to only one
class, thus failed to discriminate between both classes. The
trade-off between prediction's sensitivity and specificity
has been observed in many cases before [42] and was
thought to result from the choice of threshold value cho-
sen for making binary predictions. Similar trade-off effect
in prediction is also associated with TP (true positive) and
FP (false positive) rate.
Computation procedure used in this studyFigure 1
Computation procedure used in this study. In each round of 10 fold cross-validation, the whole dataset was randomly 
separated into training set and test set. Features that significantly differentiate the control class from the disease class are 
selected using training set only. Then test sets are classified by decision tree and ensembles using these features. Mass spec: 
mass spectrometry.Page 3 of 12
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Data preprocessing resultFigure 2
Data preprocessing result. Spectrogram ID 2 is used as an example of data preprocessing procedure. (A) Original spectro-
gram without any processing. The maximum m/z ratio is 11922.91 and the minimum m/z ratio is 800. (B) Original spectrogram 
and adjusted baseline. (C) Noise reduction using Gaussian kernel smoothing. (D) Normalization using the area under the curve 
(AUC).
Table 1: Top ten features (m/z ratio) selected by Student t test method in our 10 fold cross validation.
Rank Round 1 Round 2 Round 3 Round 4 Round 5 Round 6 Round 7 Round 8 Round 9 Round 10 Most Frequent
1 5798.9 5798.9 5819.8 5798.9 5819.8 5819.8 5798.9 5798.9 11477 5798.9 5798.9
2 5801.2 5819.8 5822.1 5801.2 5822.1 5822.1 5801.2 11541 11774 5801.2 5801.2
3 5819.8 5801.2 5798.9 5819.8 5798.9 5798.9 5819.8 11592 11472 11592 5819.8
4 5796.5 5822.1 5801.2 5822.1 5801.2 11592 5822.1 5801.2 5798.9 11597 11541
5 5822.1 11541 11592 5829.1 11770 11597 11541 11537 11481 11587 11592
6 11422 11592 11597 5831.4 11541 11587 5831.4 11546 5819.8 11541 5822.1
7 5817.4 11546 11541 11592 11597 5801.2 11592 11597 11770 11601 11597
8 11774 11587 11601 5803.5 11592 11541 11546 11774 11514 5819.8 11546
9 11541 11537 11546 11541 11601 11643 5829.1 11587 11509 11546 11601
10 11426 11569 11639 5796.5 11606 11601 11597 11601 5822.1 11606 11587
Rank is determined by the probability of the two means between disease and control groups in the training set being significantly different. m/z 
ratios with smaller probability ranks higher. Most frequent features are determined by the frequency of each feature appears in the top 10 list in 
these ten runs and ranked by their frequency.
BMC Bioinformatics 2008, 9:275 http://www.biomedcentral.com/1471-2105/9/275Besides accuracy, mean squared error of prediction (MSE)
is another important measure of performance. MSE is the
expected value of the square of "error" and consists of two
components – prediction variance and the square of the
prediction bias. In many contexts, variance and bias of a
single classifier can be effectively reduced by constructing
classifier ensemble such as Bagging and Adaboost [43,44].
Our results support this observation. For example, RMSE
(Root Mean Squared Error) of single decision tree C4.5 is
0.4687, which is higher than those of Random Forest
(0.4569), Bagging (0.4285), Logitboost (0.4402) and
Adaboost (0.4412), but interestingly smaller compared to
those of Stacked generalization (0.4761) and Multiboost
(0.5175) (Table 4). Most of the benchmark algorithms
have higher RMSE compared to either single decision tree
or classifier ensembles.
Similarly, using our top 10 features selected from the Wil-
coxon rank test (Table 5), the prediction accuracy
(66.67%) of a single decision tree is lower than those of
Random forest, Logitboost and Multiboost, but similar to
those from Stacked generalization and Bagging. The trade-
off between prediction's sensitivity and specificity still
exist for C4.5 and other classifiers. This effect is even more
obvious for Stacked generalization. In general, the classi-
fication results from t test and Wicoxon rank test have no
significant difference, indicating that both feature selec-
tion methods work equally well in this context.
In contrast, features selected from the genetic algorithm
show large variations compared to those features selected
from t test and Wilcoxon rank test. However, it is unclear
whether the classification results using genetic algorithm
also vary significantly. In our study, we observed a similar
pattern in prediction accuracy and RMSE value for genetic
algorithm (Table 6). Classifier ensembles usually outper-
form a single decision tree. For example, a single decision
tree has the lowest prediction accuracy (59%) compared
to other classifier ensembles. Interestingly, the general
performances of classifiers based on the feature selection
method of genetic algorithm are considerably lower than
those from t test and Wilcoxon rank test, possibly because
the heuristic nature of wrapper method can not guarantee
that the best features will be selected.
Recently, the area under ROC (Receiver Operating Charac-
teristic) curve (AUG) has been widely used as a measure
to compare the performance of different classifiers. Theo-
retically, AUG value equals the probability of correctly
classified one pair of samples (each from one class).
Table 3: Ten features (m/z ratio) selected by Genetic algorithm coupled with LDA in our 10 fold cross validation.
Round 1 Round 2 Round 3 Round 4 Round 5 Round 6 Round 7 Round 8 Round 9 Round 10
3385 4943.6 11555 1489.9 5939.7 1859.5 5098.2 5916 9835.1 5775.7
3304.8 5775.7 1125.2 11541 5209.5 2009.5 9578.9 2016.7 1857.2 3833.4
3186.7 4013.8 4943.6 1644 5822.1 2951.2 3760.5 3787.6 11940 3510.5
1858.7 3915.5 3383.7 4941.6 1063.5 11662 7553.5 5857.1 2756.1 1857.2
4256.8 1858 1528.6 5409.1 1644.6 11546 3540.1 3727.5 1808.1 11031
3790.7 1063.1 3959.6 1936.1 1859.5 9415.6 1860.2 1064 4532.7 5801.2
4941.6 1476.3 3726 2368.5 11463 7406.9 7966.1 5819.8 7931.2 4318.6
11027 3727.5 5829.1 3188 7592.8 6569.5 11394 9640.4 11477 11821
11426 11560 3188 1859.5 11472 1645.9 10183 1702.2 6511.9 5794.2
7085.3 2579.1 5949.2 3836.4 6509.3 1411.1 9575 6506.7 4941.6 9640.4
Table 2: Top ten features (m/z ratio) selected by Wilcoxon rank test method in our 10 fold cross validation.
Rank Round 1 Round 2 Round 3 Round 4 Round 5 Round 6 Round 7 Round 8 Round 9 Round 10 Most Frequent
1 5798.9 5798.9 4941.6 5801.2 5822.1 5819.8 5801.2 5798.9 4941.6 5801.2 5798.9
2 5801.2 5801.2 5819.8 5798.9 5819.8 5822.1 5798.9 5801.2 11774 5798.9 5801.2
3 4941.6 11472 5822.1 4941.6 5798.9 5798.9 4941.6 11472 5798.9 5796.5 11472
4 5796.5 5819.8 5801.2 5819.8 5801.2 5801.2 5803.5 11477 11770 11472 5819.8
5 5819.8 11477 5798.9 9706.1 11472 11592 5822.1 11774 11477 5803.5 5822.1
6 5822.1 5822.1 4943.6 5822.1 11477 11587 11472 11770 11472 11592 11477
7 4943.6 11468 11592 5803.5 11468 11472 5819.8 11541 5819.8 11541 11541
8 11472 5796.5 11541 5796.5 11770 11541 11477 11537 5822.1 5819.8 4941.6
9 11774 11541 11472 11472 4941.6 11774 5829.1 11468 5801.2 11477 11774
10 11477 11481 11597 9710 11774 5796.5 11541 11481 11481 11468 5796.5
Rank is determined by the probability of the two means between disease and control groups in the training set being significantly different.Page 5 of 12
(page number not for citation purposes)
BMC Bioinformatics 2008, 9:275 http://www.biomedcentral.com/1471-2105/9/275Therefore, one classifier is considered better if it has a
larger area under the ROC curve compared to a different
classifier. Thus, the AUG value under the ROC curve pro-
vides another measure of classifier performance. For
example, the AUGs of classifiers using t test selected fea-
tures are summarized in Table 7. Single decision tree C4.5
has the lowest AUG value (0.5625) while Random Forest
has the largest AUG value (0.9375) among all classifier
tested. These results strongly suggest the need to construct
classifier ensembles to analyze proteomics data.
Discussion
Sensitive detection of clinically useful biomarkers and the
building of a reliable predictor specific to pre-malignant
pancreatic cancer will certainly aid the early detection of
this deadly disease. Here, we propose the use of a more
accurate decision tree-based classifier ensembles com-
bined with feature selection methods to address some of
the challenges facing current cancer proteomics data anal-
ysis. We are able to build a low bias and a low variance
predictor using model-averaging method: classifier
ensembles. This method greatly improves the accuracy of
classification. Furthermore, the use of three feature selec-
tion methods have allowed us to select biomarkers that
achieve the best classification performance and at the
same time give us potential new insights into disease
mechanism involved in cancer development.
Biological data sets generated from proteomics studies
typically have a very high number of features compared to
their small sample sizes. Many feature selection methods
have been used in proteomic data analyses to reduce the
high dimensionality of the dataset. These include meth-
ods such as information gain [37], Kolmogorov-Smirnov
test [34] and random forest [35]. In our study, we used
three different feature selection methods: t test, Wilcoxon
rank test and genetic algorithm. These methods are
derived from the two major schemas in feature selection,
namely the filter and wrapper method [45]. Filter method
is more efficient, reliable, and not subjected to any learn-
Table 4: Classification results using features selected by Student t test.
Algorithm Accuracy(%) TP rate FP rate TN rate FN rate Sensitivity Specificity Precision Fmeasure RMSE
C4.5 0.6444 0.99 0.79 0.21 0.01 0.99 0.21 0.61 0.76 0.4687
Random Forest 0.6500 0.79 0.53 0.48 0.21 0.79 0.48 0.65 0.71 0.4569
Bagging 0.6833 0.78 0.44 0.56 0.22 0.78 0.56 0.69 0.73 0.4285
Logitboost 0.6889 0.83 0.49 0.51 0.17 0.83 0.51 0.69 0.75 0.4402
Stacking 0.6444 0.99 0.79 0.21 0.01 0.99 0.21 0.61 0.76 0.4761
Adaboost 0.6444 0.77 0.51 0.49 0.23 0.77 0.49 0.69 0.69 0.4412
Multiboost 0.6889 0.81 0.46 0.54 0.19 0.81 0.54 0.70 0.74 0.5175
Logistic 0.7500 0.79 0.30 0.70 0.21 0.79 0.70 0.78 0.78 0.4224
Naivebayes 0.6833 0.64 0.26 0.74 0.36 0.64 0.74 0.76 0.68 0.5289
Bayesnet 0.6722 0.63 0.28 0.73 0.37 0.63 0.73 0.74 0.67 0.5308
Neural Network 0.7000 0.70 0.30 0.70 0.30 0.70 0.70 0.75 0.72 0.4517
RBFnet 0.6722 0.76 0.44 0.56 0.24 0.76 0.56 0.69 0.71 0.4632
SVM 0.6944 0.71 0.33 0.68 0.29 0.71 0.68 0.74 0.71 0.5489
TP rate: True positive rate, FP rate: False positive rate, TN rate: True negative rate, FN rate: False negative rate, RMSE: Root Mean Squared Error. 
RBFnet: Radio Basis Function network, SVM: Support Vector Machine.
Table 5: Classification results using features selected by Wilcoxon rank test.
Algorithm Accuracy(%) TP rate FP rate TN rate FN rate Sensitivity Specificity Precision Fmeasure RMSE
C4.5 0.6667 0.90 0.63 0.38 0.10 0.90 0.38 0.65 0.75 0.4683
Random Forest 0.7000 0.79 0.41 0.59 0.21 0.79 0.59 0.71 0.74 0.4401
Bagging 0.6667 0.68 0.35 0.65 0.32 0.68 0.65 0.72 0.69 0.4484
Logitboost 0.6833 0.76 0.41 0.59 0.24 0.76 0.59 0.70 0.73 0.4499
Stacking 0.6667 0.93 0.66 0.34 0.07 0.93 0.34 0.64 0.76 0.4639
Adaboost 0.6611 0.76 0.46 0.54 0.24 0.76 0.54 0.68 0.71 0.4805
Multiboost 0.7000 0.73 0.34 0.66 0.27 0.73 0.66 0.74 0.73 0.5187
Logistic 0.6556 0.77 0.49 0.51 0.23 0.77 0.51 0.67 0.71 0.4362
Naivebayes 0.6944 0.70 0.31 0.69 0.30 0.70 0.69 0.77 0.72 0.4969
Bayesnet 0.6778 0.73 0.39 0.61 0.27 0.73 0.61 0.71 0.71 0.5232
Neural Network 0.6778 0.66 0.30 0.70 0.34 0.66 0.70 0.73 0.68 0.4606
RBFnet 0.5944 0.74 0.59 0.41 0.26 0.74 0.41 0.62 0.67 0.4556
SVM 0.6611 0.71 0.40 0.60 0.29 0.71 0.60 0.71 0.70 0.5760Page 6 of 12
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ture independently without regard to its relevance or the
possibility that combination of features can improve clas-
sifier performance. In contrast, the Wrapper method
chooses a particular learning algorithm as its performance
guide to consider how useful some feature combinations
are to the predictor. In genetic algorithm, the initial size of
the population sampled from the whole dataset signifi-
cantly affects the output result. Because of this, our
repeated runs using genetic algorithm failed to yield sim-
ilar results. The unreliability of genetic algorithm may
limit its future utility in proteomics data analysis. Using
the three methods mentioned earlier, we observed a gen-
erally consistent performance of all classifiers. Their accu-
racies range from 50% to 70%. Thus, feature selection
methods used here are sufficiently robust for classification
purpose.
Over the last two decades, intensive explorations of
model-averaging methods for classification purposes pro-
duce a group of efficient decision tree-based classifier
ensembles. In many different contexts, classifier ensem-
bles outperform decision tree model and other single
algorithms because of their superior ability to handle data
variance. This is also demonstrated in our result. In all
three feature selection method cases, classifier ensembles
have better prediction accuracies. Meanwhile, many
attempts were made to compare classifier ensemble tech-
niques, but most of them only focused on the two most
popular methods: Bagging and Adaboost. Although
Stacked generalization, Multiboost and Logitboost have
been proposed earlier, only recently these methods gained
greater popularity in machine learning and bioinformat-
ics community [46-48]. Until now, no direct comparisons
of their performances were made. Our study represents
the first attempt in this direction by considering them in
the context of pancreatic cancer proteomics analysis.
In general, the performances of classifiers tested on the
premalignant pancreatic cancer dataset are lower than we
had expected, with the best prediction accuracy of 70% in
a single run. There are two possible reasons for this. First,
this proteomics dataset comes from mice with histologi-
cally confirmed premalignant PanIN but no evidence of
invasive or metastatic disease [49]. Therefore, in the early
developmental stage of pancreatic cancer, the levels of
biomarkers may not exhibit significant differences
between the normal and disease group. Secondly, we used
the default parameters for all our classifiers without per-
forming any fine-tuning. The advantage of doing this is
that it can prevent the problem of "over-fitting" because
the parameters we used are not adapted to a specific data-
set, thus our method can be generalized to more datasets.
The disadvantage of using the default parameters is that
our result may not represent the best possible results.
Table 6: Classification results using features selected by genetic algorithm.
Algorithm Accuracy(%) TP rate FP rate TN rate FN rate Sensitivity Specificity Precision Fmeasure RMSE
C4.5 0.5944 0.61 0.43 0.58 0.39 0.61 0.58 0.64 0.62 0.5718
Random Forest 0.6000 0.71 0.54 0.46 0.29 0.71 0.46 0.63 0.66 0.5047
Bagging 0.6111 0.64 0.43 0.58 0.36 0.64 0.58 0.66 0.65 0.4965
Logitboost 0.6167 0.68 0.46 0.54 0.32 0.68 0.54 0.65 0.66 0.5153
Stacking 0.6056 0.66 0.46 0.54 0.34 0.66 0.54 0.65 0.65 0.4892
Adaboost 0.6167 0.67 0.45 0.55 0.33 0.67 0.55 0.65 0.65 0.5960
Multiboost 0.6111 0.68 0.48 0.53 0.32 0.68 0.53 0.65 0.66 0.6147
Logistic 0.6056 0.67 0.48 0.53 0.33 0.67 0.53 0.63 0.65 0.5122
Naivebayes 0.6000 0.76 0.60 0.40 0.24 0.76 0.40 0.62 0.67 0.5251
Bayesnet 0.5611 0.73 0.65 0.35 0.27 0.73 0.35 0.59 0.65 0.5110
Neural Network 0.5944 0.61 0.43 0.58 0.39 0.61 0.58 0.65 0.62 0.5814
RBFnet 0.6000 0.69 0.51 0.49 0.31 0.69 0.49 0.63 0.65 0.5038
SVM 0.6333 0.72 0.48 0.53 0.28 0.72 0.53 0.66 0.68 0.5985
Table 7: AUG results of classifiers
Algorithm AUG Algorithm AUG Algorithm AUG Algorithm AUG
C4.5 0.5625 Logitboost 0.8438 Bayes Net 0.8563 RBFnet 0.9
Random Forest 0.9375 Stacking 0.5625 Logistic 0.925 SVM 0.7
Random Tree 0.825 Adaboost 0.85 Neural Network 0.85
Bagging 0.85 Multiboost 0.875 Naïve Bayes 0.8875Page 7 of 12
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We presented a systematic machine learning method to
analyze cancer proteomics data that utilized decision tree
based classifier ensembles and three popular feature selec-
tion schemas in a cross validation framework. Our
method includes three steps: preprocessing, feature selec-
tion and classification. The proposed method is general
enough that it can be adapted to other proteomics data
analysis problems. Our results show that classifier ensem-
bles perform significantly better than single decision tree
algorithm, highlighting the utility of classifier ensembles
in future proteomics research. Additionally, biomarkers
selected in this process may shed new lights on processes
and mechanisms underpinning cancer development. Our
study represents one of the first attempts to apply and
compare decision tree based classifier ensembles in the
context of cancer proteomics data analysis. Results pre-
sented here will open up other possibilities for further
research.
Methods
Premalignant pancreatic cancer mass-spectrometry data
Pancreatic cancer peptide mass-spectrometry data was
downloaded from the FDA-NCI Clinical Proteomics Pro-
gram [50]. This dataset was generated from serums of 33
mice (5.5 ± 0.25 months) that carried low-level burdens
of human pancreatic intraepithelial neoplasias (PanINs)
cells that were induced by endogenous expression of
KRASG12D, and 39 age-matched control mice [49]. There
are a total of 80 PanINs serum samples that are referred to
as disease group and 101 control serum samples that are
referred to as control group. For each serum sample, the
data stream was binned using a fraction of 400 parts per
million (ppm), thus condensed the data from 350,000 to
6771 data points. The m/z ratios range from 800 to
11992.91.
Mass-spectrometry data preprocessing
In general, a typical mass-spectrometry data set contains
several thousands of intensity measurements. Many fac-
tors such as system artifacts make mass-spectrometry data
extremely noisy. Therefore, low-level preprocessing is crit-
ical to the success of data analysis [51]. Theoretically,
observed mass spectra can be decomposed into three
components [52]:
f(i, j) = b(i, j) + s(i, j) + ε (i, j) (1)
where f(i, j) is the observed value, b(i, j) is the baseline
value, s(i, j) is the true signal and ε (i, j) is the noise for ith
sample at jth m/z ratio. Baseline is considered to be the
low frequency component of the observed signal and its
variability arises from different sources such as sample ion
dispensing, matrix chemical contamination and data col-
lection. This problem is especially significant at low peak
intensity because the noise to signal ratio is larger. Some
of the baseline correction algorithms are summarized in
[53]. To adjust for our baseline problem, we first esti-
mated our baseline by segmenting the whole spectra into
windows with a size of 200 m/z ratio intensities. We then
used the mean value of these windows as the estimate of
baseline value at that intensity [54]. Then a piecewise
cubic interpolation method was used to perform regres-
sion, thereby avoiding the problem of sharp boundary.
This procedure was applied to all spectrograms.
In mass spectrometry data, systematic differences between
replicate experiments are often significant enough to pre-
vent the drawing of any meaningful conclusion. To com-
pensate for these systematic differences, we normalized
the intensities of all spectrograms from the downloaded
dataset. Many normalization methods developed for
mass-spectrometry data are available and some of them
have been successfully used in previous analysis [55-57].
Area under curves (AUC) which is defined as , where
yi is the signal at ith m/z ratio, is used to measure the pro-
tein concentration in mass-spectrometry data. In this
study, we standardized each spectrum based on the ratio
of its area under curves (AUC) over the median calculated
from all spectra [57]. Also, the maximum intensities from
each spectrogram are rescaled to 100.
Raw mass spectrometry data typically contains signal and
random noise introduced by factors such as instrument
measurement error. Thus, it is important to reduce the
noise in the data to improve the quality of the spectro-
grams. This enables feature selection schema to select sig-
nificant features. We adopted a Gaussian kernel
smoothing method to reduce the noise in our data.
Assuming the signals are generated from a Gaussian distri-
bution, we substitute each original data point value with
a weighted average of all samples close to it. Each nearby
data point × contributes according to its distance in a
Gaussian form. Weights are determined by
 where dist is the distance between this
point and the center point and dmax is the maximum dis-
tance of all points and center point. In this work, we used
bandwidth 10 to allow a reasonably large distribution
such that there will be a five points on each side of the
original data point.
Feature selection
Two-sample student t test considers each feature inde-
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statistics is calculated as follows:
Where xd and xc are the mean values of intensities from
disease group and control group respectively. vard and varc
are variances of two distributions. nd and nc are the num-
bers of instance in each distribution. This t value follows
student t distribution with degree of freedom nd + nc-2.
The significance p value is calculated based on test statis-
tics and t distribution.
Wilcoxon rank test is a nonparametric test which has no
distribution assumption. All the data are ranked together
based on their values. Then the ranks from one class are
compared with those from the other class. The U statistics
is calculated as:
where nd and Rd are the size and sum of ranks in disease
samples. An equally valid formula for U is to replace all
values from control sample.
Although Wilcoxon rank test is robust against parameter
variation and makes no distribution assumption, in situa-
tion such as proteomics data where the sample size is
small, the P values calculated by Wilcoxon rank test tend
to be higher. Therefore, it is not easy to detect statistically
real difference. On the other hand, student t test can dif-
ferentiate between these cases (if the distribution approx-
imates Normal), thus is more powerful than
nonparametric test in this context.
The wrapper method used in this study incorporate
genetic algorithm as feature space search procedure.
Genetic algorithm is a heuristic method. It adopts ideas
from the field of evolutionary genetics, such as popula-
tion, inheritance, cross-over, mutation and selection. Evo-
lution starts from a group of randomly generated feature
sets: the initial population. Individual's fitness (perform-
ance) is evaluated by a learning algorithm. The mutation
process usually selects the individual with good fitness
score from the parent population to form the next gener-
ation. Normally, the fitness of descendent population is
better than their "parent" population. This process contin-
ues until the termination condition where fitness reaches
maximum. Features in the final population will be
reported. Factors such as the initial population, mutation
rate, and local maximum can affect the performance of
genetic algorithm. In general, genetic algorithm gives rea-
sonably satisfactory result quickly.
Decision tree ensemble algorithms
Decision tree is one of the most popular predictor used in
machine learning community and is commonly used as a
base learner in constructing classifier ensemble [58]. In
decision tree algorithm, the approximated target function
is represented as a tree-like structure. In general, it works
by sorting down the tree branch from the root to some leaf
nodes. Each internal node represents a specific test of
instance attribute, and each branch represents one of the
possible test results. The classical decision algorithm C4.5
[59] implements a top-down greedy search schema to
search through all possible tree spaces. At each split, they
try every possible feature to achieve maximum reduction
of impurity. Decision tree is efficient, easy to interpret and
robust but may suffer from low accuracy and high vari-
ance. Thus, many attempts were made to improve it using
model averaging method.
Bagging (Bootstrap Aggregating) represents one of the
first successful attempts to use model averaging method.
It was originally proposed by Leo Breiman [60]. To build
ensembles, Bagging repeatedly samples the training set
data to form subset with replacement following a uniform
probability distribution. Thus in each subset, one instance
can appears more than once. One classifier is trained for
each newly formed subset. The final classification result is
determined by the unweighted votes of each classifier in
the committee, thus aggregating all classifiers:
Where H(x) is the final committee vote result, hi is the
result from individual classifier.
AdaBoost [61] is similar to Bagging in that both of them
resample from the base of the training set. However, one
of the major differences between them is that AdaBoost
associates a different weight to each instance based on
previous classification result. All instances are assigned
equal weights at the beginning. After first round of classi-
fication, instances that are classified correctly will receive
smaller weights in the next round. Instances that are
incorrectly classified will have larger weights. By normal-
izing these weights to form another distribution, Ada-
Boost will sample from new distribution to train another
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weight and result from individual predictors.
In the context of binary classification, the above Adaboost
algorithm can be called discrete Adaboost. Friedman et al.
[62] proved that Boosting algorithm is a stage-wise esti-
mation procedure for fitting additive logistic regression
model by minimizing an exponential criterion. This crite-
rion is equivalent to a second order binomial log-likeli-
hood criterion in the Taylor's series. Based on this
discovery, they explored the possibility of using Bernoulli
log-likelihood criterion, which in turn, called Logitboost.
Friedman et al. showed that Logitboost could achieve
equivalent level of performance compared to Adaboost
[62] using a collection of datasets from the data repository
located at University of California (Irvine).
Since the successful introduction of Bagging and Boosting
algorithms, many investigators have tried to combine the
power of variance reduction from Bagging and bias reduc-
tion from Adaboost. One attempt is Multiboost [63]. It
tries to combine the benefits offered from both Bagging
and Adaboost by exploring Wagging (Weight Aggregating,
a variant of bagging), a set of committee formed by Ada-
boost. It also has an advantage in computation because
these committees can learn in parallel. Wagging, which
also repeatedly perturb the training data, does not sample
the data to form smaller subsets. Instead, it adds noises to
all weights such that it no longer assumes a uniform dis-
tribution. Thus, wagging take full advantage of the dataset
without leaving any of the data unused. Using University
of California (Irvine) repository datasets, Multiboost algo-
rithm was frequently shown to achieve lower error than
either Bagging or Boosting [63].
Random forest is another type of tree ensemble [64]. It
can be considered as Bagging with random feature selec-
tion. In the forest, each tree is built using a bootstrap sam-
ple of the data. Candidate feature set is selected randomly
at all tree splits. Randomness in the algorithm guarantees
that low level of correlation between trees. In addition,
each tree grows fully without any pruning. Thus, both var-
iance and bias reduction can be achieved at the same time.
All the above algorithms have only one level in that all
parallel trees take the original input data and provide one
output prediction result. In contrast, Stacking [65] is a
method that combines multiple level models for classifi-
cation. Usually, there are two levels of classifiers. The first
level classifiers are trained on the original input data, and
their outputs are collected into a new dataset. This new
dataset in turn serves as an input data for a second level
learning algorithm that produce the final result. Many dif-
ferent combinations of level one and level two classifiers
have been tested. Ting and Witten [66] showed that they
can achieve the least error rate compared to other classifi-
ers using output class probability together with least
squares linear regression as their second level generalizer.
Also, bench mark algorithms such as Logistic Regression,
Naïve Bayes, Bayes Net, Neural Network, Radial Basis
Function Network and Support Vector Machine are also
used in this study for the purpose of comparison.
Classifier performance measurement
Ten fold cross validation is known to be a good estimator
of classifier's performance. Ten percent of the data from
the whole dataset are chosen randomly as test set while
the remaining 90 percent are used as training set. This
process is repeated 10 times and the average result is
reported. In each run, prediction results can be classified
into four groups: TP (true positive), FP (false positive), TN
(true negative) and FN (false negative). Thus
And MSE (Mean Squared Error) can be decomposed as
Where  is the estimator of parameter θ.
There is always a trade-off between sensitivity and specifi-
city because of the different threshold values used in
binary prediction. Thus, ROC (Receiver Operating Char-
acteristic) curve is used to plot true/false positive rates or
sensitivity/1-specificity for different thresholds. The area
under the ROC curve (AUG) equals the probability of cor-
rectly classified one pair of samples, each one from a sep-
arate class. It has been used as an important measurement
of classifier performance. A classifier is considered a pre-
ferred classifier compared to the other classifier if it has a
larger AUG value. A random classifier has an area of
approximately 0.5 under the ROC graph, whereas a per-
fect classifier has an area of 1.
Weka machine learning package was used in the simula-
tion of classifier ensembles [67]. We also used Matlab sta-
tistics and bioinformatics toolbox in the data
preprocessing and feature selections.
Accuracy
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